MKI67 and prostate cancer: However, in a cohort of prostate cancer patients diagnosed with needle biopsies and managed by surveillance, 27% of the ISUP grade 1 patients had a Ki67 labelling index greater than 5%, a cell proliferation rate associated with an increased risk of disease progression [26].